Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

The Dow Jones Industrial Average rose 300 points late on ... those that compare GDP to the previous quarter e.g Q2 of 2023 vs Q1 of 2023, or to the same period in the previous year, e.g Q2 of ...

The S&P 500 index was leading the equity gauges higher with a 0.8% gain, versus a 0.6% advance for the blue-chip Dow Jones Industrial Average and the tech-heavy Nasdaq Composite's 0.6% advance ...

the Dow Jones Industrial Average tracks the performance of 30 prominent stocks that investors trade most often. Are futures riskier than options? Understand the risks of futures vs options trading ...

Benchmark indices Sensex and Nifty 50 continued their upward trend, supported by the Economic Survey 2024-25, which projected ...

President Trump has OK'd tariffs vs. Canada, Mexico and China, and he says more are coming. Amazon, Google and Palantir earnings loom.

On Thursday, the Dow Jones Industrial Average and S&P 500 were trading 0.38% and ... Total income up 17.4% at Rs 598 crore vs Rs 509 crore Net profit up 25.5% at Rs 146 crore vs Rs 117 crore Ajanta ...

Enveric Biosciences said its lead candidate for treating mental-health disorders was a big step closer toward winning patent protection ... connor.hart@wsj.com About Dow Jones Newswires Dow ...

With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.

and in the Local Divisions of Mannheim and Düsseldorf in the Unified Patent Court. InterDigital has been innovating in video and related innovation for decades and is a leader in the development ...

On Wednesday, the Dow Jones Industrial Average (DJIA) remained steady, hovering around 44,700, shedding around 130 points but holding steady through the midweek market session. The major equity ...

(RTTNews) - Atossa Therapeutics, Inc. (ATOS), a Washington-based biopharmaceutical company, has released a statement addressing the PTAB's final decision in PGR2023-00043 concerning U.S. Patent No ...